Clinical Trials Search

Department: Cardiology
Diagnosis: Cardiac - Arrhythmia
Sponsor: Janssen
Indentifier #: NCT01877915
Title: A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Oral Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects with Chronic Heart Failure and Significant Coronary Artery Disease Following a Hospitalization for Exacerbation of Heart Failure COMMANDER HF Study
Department: Cardiology
Diagnosis: Cardiac - Hyperlipidemia
  • Kondareddy M.D., Shreekanth R.
  • Rudzinski M.D., Wojciech
Sponsor: Pfizer
Indentifier #: NCT01968967
Title: B1481020, A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of PF-04950615 Following Subcutaneous Dosing for 52 Weeks in Subjects with Primary Hypercholesterolemia or Mixed Dyslipidemia, at High and Very High risk of Cardiovascular Events, Not Controlled with Lipid Lowering Therapy